Replies to post #120048 on Biotech Values

[DewDiligence]

Are you saying somebody can read this IP and get clues and come up with a different, non-infringing way of making biosimilar?

Clearly, there’s a tradeoff here. Patenting a manufacturing process may have value, but no company wants to show its competitors any more that it has to.